GB Patent

GB2571749A — A method inducing satiety in a mammal

Assigned to Anabio Technologies Ltd · Expires 2019-09-11 · 7y expired

What this patent protects

A therapeutic or non-therapeutic method of inducing satiety in a mammal is described. The method comprises administering to the mammal a composition comprising microparticles in which the microparticles comprise lipid, contained within a gastric-resistant, ileal­-sensitive shell …

USPTO Abstract

A therapeutic or non-therapeutic method of inducing satiety in a mammal is described. The method comprises administering to the mammal a composition comprising microparticles in which the microparticles comprise lipid, contained within a gastric-resistant, ileal­-sensitive shell that are configured for release of the lipid in the ileum and wherein the composition is administered 1-3 hours prior to a meal.

Drugs covered by this patent

Patent Metadata

Patent number
GB2571749A
Jurisdiction
GB
Classification
—
Expires
2019-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Anabio Technologies Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.